 |
市場調查報告書
商品編碼
1638820
2024 - 2032 年遠距藥局市場機會、成長動力、產業趨勢分析與預測Telepharmacy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
||||||
2023 年全球遠距藥局市場價值為 99 億美元，預計 2024 年至 2032 年將以 10.4% 的年複合成長率(CAGR) 成長。它允許藥劑師提供一系列服務，包括用藥諮詢、處方驗證和患者監測，而無需患者親自前往藥房。這種方法有助於改善醫療保健的可近性，特別是在服務不足或農村地區，並簡化藥物管理。
市場成長是由對可獲得的醫療保健解決方案的需求不斷成長所推動的，特別是在傳統藥房服務稀缺的地區。透過使患者能夠透過數位平台向執業藥劑師諮詢，遠距藥局消除了旅行的需要並增強了便利性。隨著醫療保健提供者尋求更安全、遠距的病患照護選擇，COVID-19 大流行在促進遠距藥局的採用方面發揮了重要作用。
市場分為兩個主要類別：軟體和服務。軟體細分市場將在 2023 年引領市場，預計將繼續強勁成長，預測期內複合年成長率預計為 10.7%。這一成長歸因於對支持遠端諮詢、處方管理和持續患者監測的先進遠端藥房平台的需求不斷成長。這些平台提供安全視訊會議、即時資料共享以及藥劑師和患者之間的無縫通訊等功能，有助於細分市場的擴展。
| 市場範圍 | |
|---|---|
| 開始年份 | 2023年 |
| 預測年份 | 2024-2032 |
| 起始值 | 99 億美元 |
| 預測值 | 236 億美元 |
| 複合年成長率 | 10.4% |
對醫療保健 IT 的投資不斷增加以及對資料隱私合規性的需求不斷成長是軟體領域的關鍵驅動力。隨著越來越多的醫療保健服務轉向數位平台，遠距藥局軟體在提高藥物依從性、患者參與度和整體藥物服務可近性方面發揮著至關重要的作用。
從最終用戶來看，遠距藥局市場分為醫院藥局、零售藥局和其他用戶。由於擴大使用遠端藥房來管理遠端諮詢、藥物管理和患者支持，醫院藥房在 2023 年佔據了最大的市場佔有率。此細分市場受益於為農村和服務欠缺地區的患者提供護理的能力，同時減少患者前往服藥的需要。
北美的遠距藥局市場尤其強勁，醫療基礎設施、先進技術和有利法規的大量投資推動了市場成長。對遠距醫療服務的需求，特別是在農村社區，持續成長，進一步支持了遠距藥局在整個地區的擴張。隨著數位健康解決方案受到關注，遠距藥局正在成為現代醫療保健服務的重要組成部分。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 遠距醫療需求增加
- 慢性病盛行率上升
- 支持性法規政策
- 電信技術和軟體解決方案不斷進步
- 產業陷阱與挑戰
- 患者意識有限
- 資料安全問題
- 成長動力
- 成長潛力分析
- 未來市場趨勢
- 監管環境
- 技術景觀
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 公司矩陣分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按軟體和服務分類，2021 - 2032 年
- 主要趨勢
- 軟體
- 本地
- 基於網路/基於雲端
- 服務
- 遠程點膠
- 遠距患者諮詢
- 遠端訂單輸入審核
- 藥物治療監測
- 其他服務
第 6 章：市場估計與預測：依最終用途，2021 - 2032 年
- 主要趨勢
- 醫院藥房
- 零售藥局
- 其他最終用戶
第 7 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
第 8 章：公司簡介
- AZOVA
- Cardinal Health
- CarepathRx
- CPS Solutions
- Indispensable Health
- Infinipharm
- Medication Review
- OSP
- Outcomes
- PipelineRx
- Right ePharmacy
- Zane Networks
The Global Telepharmacy Market was valued at USD 9.9 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2032. Telepharmacy refers to the use of technology to deliver pharmaceutical services remotely. It allows pharmacists to provide a range of services, including medication counseling, prescription verification, and patient monitoring, without requiring patients to visit the pharmacy in person. This approach helps improve access to healthcare, especially in underserved or rural regions, and streamlines medication management.
The market growth is driven by the increasing demand for accessible healthcare solutions, particularly in areas where traditional pharmacy services are scarce. By enabling patients to consult with licensed pharmacists via digital platforms, telepharmacy eliminates the need for travel and enhances convenience. The COVID-19 pandemic played a significant role in boosting telepharmacy adoption as healthcare providers sought safer, remote options for patient care.
The market is divided into two primary categories: software and services. The software segment led the market in 2023 and is expected to continue its strong growth, with a projected CAGR of 10.7% during the forecast period. This growth is attributed to the rising demand for advanced telepharmacy platforms that support remote consultations, prescription management, and continuous patient monitoring. These platforms offer features like secure video conferencing, real-time data sharing, and seamless communication between pharmacists and patients, contributing to segment expansion.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $9.9 Billion |
| Forecast Value | $23.6 Billion |
| CAGR | 10.4% |
The increasing investment in healthcare IT and the growing need for data privacy compliance are key drivers for the software segment. As more healthcare services transition to digital platforms, telepharmacy software plays a crucial role in improving medication adherence, patient engagement, and overall accessibility to pharmaceutical services.
In terms of end users, the telepharmacy market is segmented into hospital pharmacies, retail pharmacies, and other users. Hospital pharmacies accounted for the largest market share in 2023, driven by their growing use of telepharmacy to manage remote consultations, medication administration, and patient support. This segment benefits from the ability to provide care to patients in rural and underserved areas while reducing the need for patients to travel for medications.
The telepharmacy market is particularly strong in North America, where significant investments in healthcare infrastructure, advanced technology, and favorable regulations drive market growth. The demand for remote healthcare services, particularly in rural communities, continues to rise, further supporting the expansion of telepharmacy across the region. As digital health solutions gain traction, telepharmacy is becoming a vital component of modern healthcare delivery.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increased demand for remote healthcare
- 3.2.1.2 Rising chronic disease prevalence
- 3.2.1.3 Supportive regulations and policies
- 3.2.1.4 Growing technology advancement in telecommunication technologies and software solutions
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Limited awareness among patients
- 3.2.2.2 Data security concerns
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Future market trends
- 3.5 Regulatory landscape
- 3.6 Technology landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Software & Services, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Software
- 5.2.1 On-premises
- 5.2.2 Web-based/cloud-based
- 5.3 Services
- 5.3.1 Remote dispensing
- 5.3.2 Remote patient counseling
- 5.3.3 Remote order-entry review
- 5.3.4 Drug therapy monitoring
- 5.3.5 Other services
Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Hospital pharmacies
- 6.3 Retail pharmacies
- 6.4 Other end users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 AZOVA
- 8.2 Cardinal Health
- 8.3 CarepathRx
- 8.4 CPS Solutions
- 8.5 Indispensable Health
- 8.6 Infinipharm
- 8.7 Medication Review
- 8.8 OSP
- 8.9 Outcomes
- 8.10 PipelineRx
- 8.11 Right ePharmacy
- 8.12 Zane Networks
